These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

895 related articles for article (PubMed ID: 190267)

  • 1. Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions.
    Minkes M; Stanford N; Chi MM; Roth GJ; Raz A; Needleman P; Majerus PW
    J Clin Invest; 1977 Mar; 59(3):449-54. PubMed ID: 190267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic AMP and platelet prostaglandin synthesis.
    Gerrard JM; Peller JD; Krick TP; White JG
    Prostaglandins; 1977 Jul; 14(1):39-50. PubMed ID: 197570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory role of cyclic adenosine 3',5'-monophosphate on the platelet cyclooxygenase and platelet function.
    Fitzpatrick FA; Gorman RR
    Biochim Biophys Acta; 1979 Jan; 582(1):44-58. PubMed ID: 216415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
    Brammer JP; Maguire MH
    Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benzodiazepines inhibit human platelet activation: comparison of the mechanism of antiplatelet actions of flurazepam and diazepam.
    Romstedt K; Huzoor-Akbar
    Thromb Res; 1985 May; 38(4):361-74. PubMed ID: 2990062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interrelation of prostaglandin endoperoxide (prostaglandin G2) and cyclic 3',5'-adenosine monophosphate in human blood platelets.
    Salzman EW
    Biochim Biophys Acta; 1977 Aug; 499(1):48-60. PubMed ID: 196670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impairment of platelet thromboxane A2 generation and of the platelet release reaction in two patients with congenital deficiency of platelet cyclo-oxygenase.
    Lagarde M; Byron PA; Vargaftig BB; Dechavanne M
    Br J Haematol; 1978 Feb; 38(2):251-66. PubMed ID: 205238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
    Patscheke H; Stegmeier K
    Thromb Res; 1984 Feb; 33(3):277-88. PubMed ID: 6424261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutathione disulfide production during arachidonic acid oxygenation in human platelets.
    Burch JW; Burch PT
    Prostaglandins; 1990 Feb; 39(2):123-34. PubMed ID: 2107565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of imidazole as a selective inhibitor thromboxane synthetase in human platelets.
    Needleman P; Raz A; Ferrendelli JA; Minkes M
    Proc Natl Acad Sci U S A; 1977 Apr; 74(4):1716-20. PubMed ID: 193113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between cyclic AMP and thromboxane formation in platelet-endothelial cell interactions.
    Lagarde M; Felisi O; Boukhchache D; Sicard B; Dechavanne M
    Thromb Res; 1984 Jul; 35(2):141-7. PubMed ID: 6089369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade combined in one molecule--I. Biochemical profile in vitro.
    De Clerck F; Beetens J; de Chaffoy de Courcelles D; Freyne E; Janssen PA
    Thromb Haemost; 1989 Feb; 61(1):35-42. PubMed ID: 2546278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inhibitory effects of exogenous arachidonic acid on rabbit platelet aggregation and the release reaction.
    Cattaneo M; Kinlough-Rathbone RL; Perry DW; Chahil A; Vickers JD; Lam SC; Packham MA; Mustard JF
    Blood; 1982 Nov; 60(5):1179-87. PubMed ID: 6289942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological activity and metabolism of 20-hydroxyeicosatetraenoic acid in the human platelet.
    Hill E; Fitzpatrick F; Murphy RC
    Br J Pharmacol; 1992 Jun; 106(2):267-74. PubMed ID: 1327375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of platelet arachidonic acid oxygenation by cyclic AMP.
    Schafer AI; Levine S; Handin RI
    Blood; 1980 Nov; 56(5):853-8. PubMed ID: 6252992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of vinblastine on malondialdehyde formation, serotonin release and aggregation in human platelets.
    Brammer JP; Kerecsen L; Maguire MH
    Eur J Pharmacol; 1982 Jul; 81(4):577-85. PubMed ID: 6811295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triene prostaglandins: prostacyclin and thromboxane biosynthesis and unique biological properties.
    Needleman P; Raz A; Minkes MS; Ferrendelli JA; Sprecher H
    Proc Natl Acad Sci U S A; 1979 Feb; 76(2):944-8. PubMed ID: 218223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides.
    Gryglewski RJ; Bunting S; Moncada S; Flower RJ; Vane JR
    Prostaglandins; 1976 Nov; 12(5):685-713. PubMed ID: 824685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet desensitization induced by arachidonic acid is not due to cyclo-oxygenase inactivation and involves the endoperoxide receptor.
    Carmo LG; Hatmi M; Rotilio D; Vargaftig BB
    Br J Pharmacol; 1985 Aug; 85(4):849-59. PubMed ID: 2994786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.
    Hamberg M; Svensson J; Samuelsson B
    Proc Natl Acad Sci U S A; 1975 Aug; 72(8):2994-8. PubMed ID: 1059088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.